Clinical trial Recruiting at 1 site Observational Ages 15 and up

Patients controlling their own admissions to inpatient care

Official title: Patient-controlled Admissions to Inpatient Care for Patients With Severe Psychiatric Conditions in Region Stockholm

Run by Karolinska Institutet · NCT04862897 · Data updated 2026-11-12

This study tests whether letting patients with severe mental health issues decide when to go into the hospital can improve their control over their care and overall well-being.

More Healthy Controls Group - Age and Sex-matched trials

Quick facts

Study typeObservational
Ages15 Years and up
SexAll
Enrollment564 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm, Stockholm County)
StatusRecruiting
StartedJanuary 1, 2020
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedSeptember 16, 2025
Trial IDNCT04862897 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with severe psychiatric conditions who have ongoing outpatient care and a history of inpatient treatment.

Probably not a fit

Patients who do not have the capacity to provide informed consent or those without a prior inpatient care history may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the implementation of patient-controlled admissions for individuals with severe psychiatric conditions in Region Stockholm, Sweden. It aims to empower patients by allowing them to admit themselves to inpatient care when needed, rather than relying solely on healthcare providers to make that decision. The approach is designed to enhance patient autonomy, reduce involuntary admissions, and improve overall quality of life. The study will involve patients who have ongoing contact with outpatient care and have previously required inpatient treatment.

Why it matters

Potential benefit: If successful, this approach could significantly enhance patient autonomy and reduce the need for involuntary psychiatric admissions.

How similar studies have gone: Previous smaller studies have shown positive outcomes for patient-controlled admissions, indicating potential for success in this larger implementation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have an on-going contact with outpatient care.
* Have an individual care plan and crisis plan.
* Have had at least one inpatient care period the previous year.
* Are expected to have the greatest need of inpatient care.
* Are interested in, and understand the concept of, patient-controlled admissions.

Exclusion Criteria:

* No informed consent to participate in the research project (concerns only self-reported outcomes).

Matched control group:

\- A matched control group consisting of seven times the number of of patients receiving patient-control admissions will be utilised for all primary outcome measures, other psychiatric or somatic healthcare consumption, sick-leave, and redeemed prescriptions (matched on account of age, gender, diagnosis, and history of psychiatric inpatient care, but who have not been granted access to patient-controlled admissions)

Where it's running

  • Centre for Psychiatry Research
    Stockholm, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.